全文获取类型
收费全文 | 4527篇 |
免费 | 214篇 |
国内免费 | 51篇 |
专业分类
耳鼻咽喉 | 77篇 |
儿科学 | 55篇 |
妇产科学 | 25篇 |
基础医学 | 566篇 |
口腔科学 | 79篇 |
临床医学 | 322篇 |
内科学 | 1445篇 |
皮肤病学 | 75篇 |
神经病学 | 360篇 |
特种医学 | 114篇 |
外科学 | 610篇 |
综合类 | 48篇 |
预防医学 | 131篇 |
眼科学 | 60篇 |
药学 | 216篇 |
中国医学 | 9篇 |
肿瘤学 | 600篇 |
出版年
2023年 | 50篇 |
2022年 | 92篇 |
2021年 | 155篇 |
2020年 | 84篇 |
2019年 | 131篇 |
2018年 | 127篇 |
2017年 | 87篇 |
2016年 | 122篇 |
2015年 | 110篇 |
2014年 | 158篇 |
2013年 | 168篇 |
2012年 | 239篇 |
2011年 | 305篇 |
2010年 | 154篇 |
2009年 | 116篇 |
2008年 | 210篇 |
2007年 | 233篇 |
2006年 | 199篇 |
2005年 | 223篇 |
2004年 | 210篇 |
2003年 | 213篇 |
2002年 | 173篇 |
2001年 | 136篇 |
2000年 | 141篇 |
1999年 | 117篇 |
1998年 | 48篇 |
1997年 | 39篇 |
1996年 | 32篇 |
1995年 | 22篇 |
1994年 | 19篇 |
1993年 | 17篇 |
1992年 | 58篇 |
1991年 | 61篇 |
1990年 | 63篇 |
1989年 | 54篇 |
1988年 | 50篇 |
1987年 | 51篇 |
1986年 | 37篇 |
1985年 | 48篇 |
1984年 | 27篇 |
1983年 | 21篇 |
1980年 | 12篇 |
1979年 | 16篇 |
1977年 | 12篇 |
1976年 | 11篇 |
1972年 | 16篇 |
1971年 | 11篇 |
1970年 | 12篇 |
1968年 | 15篇 |
1967年 | 9篇 |
排序方式: 共有4792条查询结果,搜索用时 15 毫秒
101.
Okumura Takahiro Matsuda Keisuke Fukuoka Yu Dai Junya Shiraishi Naoko 《Journal of artificial organs》2021,24(3):320-326
Journal of Artificial Organs - In Japan, perfusionists who work on other clinical tasks are involved in cardiopulmonary bypass. Moreover, the number of cases they can perform is limited. In view of... 相似文献
102.
Junya Fukuoka Masaki Tominaga Kazuya Ichikado Tomonori Tanaka Hidenori Ichiyasu Hirotsugu Kohrogi Shin Ishizawa Moritaka Suga 《Pathology international》2013,63(2):108-112
Human T‐cell leukemia virus type 1 (HTLV‐1) carriers are rarely subject to inflammatory disorders in multiple organs, other than the well‐known complication, adult T‐cell leukemia/lymphoma (ATLL). HTLV‐1 associated bronchiolo‐alveolar disorder (HABA) has been proposed as an immune mediated pulmonary reaction seen rarely in HTLV‐1 carriers. The reported clinico‐pathological patterns of HABA are diffuse panbronchiolitis (DPB) and lymphoid interstitial pneumonia (LIP). We here report three cases of HTLV‐1 carriers showing miliary micro‐nodules throughout both lungs. Microscopic examination in the video assisted thoracic surgery biopsies demonstrated that all cases had multiple discrete micro‐nodules which consisted of marked lymphoid infiltration, granulomas, eosinophils and a few foci of necrosis inside the granuloma. No findings indicating ATLL, other neoplastic conditions, infection or interstitial pneumonia, including DPB and LIP, were present following panels of special staining and immunohistochemical examinations. Two patients improved without treatment within one month, with no evidence of recurrence after 7 years. One patient showed slow deterioration of lung reticular shadows in spite of a low dose corticosteroid therapy (prednisolone 10 mg/day). We believe these cases may be a newly recognized variant of HABA. 相似文献
103.
Reo Kanda Chieko Hamada Kayo Kaneko Takanori Nakano Keiichi Wakabayashi Hiroaki Io Satoshi Horikoshi Yasuhiko Tomino 《Journal of artificial organs》2013,16(1):66-73
It is well known that bioincompatible peritoneal dialysate plays a central role in the development of peritoneal fibrosis. Peritoneal inflammation continues even after the cessation of peritoneal dialysate stimulation. It is important to establish the definition of persistent inflammation in the peritoneal cavity at the cessation of peritoneal dialysis (PD). The objective of the present study was to determine whether pentraxin 3 (PTX3) in peritoneal effluent (PE) may be a new biomarker in PD patients. Serum, PE, and peritoneal specimens were obtained from 50 patients with end-stage kidney disease at Juntendo University Hospital. Samples of 19 patients were obtained at the initiation of PD and those of 31 patients at the cessation of PD. PTX3, high-sensitivity CRP, and MMP-2 and IL-6 were analyzed. An immunohistological examination using an anti-PTX3 antibody was performed. Expressions of PTX3 were observed in endothelial cells, fibroblasts, and mesothelial cells in the peritoneum. The PTX3 level in PE at the cessation of PD was significantly higher than that at the initiation of PD. Effluent PTX3 levels in patients with a history of peritonitis or a PD duration of more than 8 years were significantly higher than those in patients without peritonitis or patients with a PD duration of <8 years. The PTX3 level was significantly correlated with MMP-2 and IL-6 levels in PE, as well as the thickness of the submesothelial compact zone and the vasculopathy. It appears that PTX3 may be a new biomarker of peritoneal inflammation and progressive fibrosis. 相似文献
104.
Masato Nakamura Tatsuo Kanda Tatsuo Miyamura Shuang Wu Shingo Nakamoto Osamu Yokosuka 《International journal of medical sciences》2013,10(8):1015-1021
Alanine aminotransferase (ALT) elevation was occassionally observed during the treatment with combination peginterferon alpha plus ribavirin. Two forms of peginterferon are currently available as a standard of care with or without direct-acting antivirals against hepatitis C virus (HCV). Until the appearance of interferon-sparing regimen, peginterferon alpha plus ribavirin will play a central role in the eradication of HCV. In the present study, we compared ALT elevations in response to peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin in HCV genotype-1-infected patients. There were no significant differences in ALT elevations between treatments with the two peginterferons, but in a comparison of the proportions of patients with transient ALT elevation from baseline between the two groups, transient ALT elevation was observed more in sustained virological response (SVR) patients treated with peginterferon alpha-2a than with peginterferon alpha-2b. However, no patients discontinued treatment due to ALT elevation. Patients with transient ALT elevation from baseline during the treatment had less favorable IL28B rs8099917 genotype in the peginterferon alpha-2b group. Patients achieving SVR tended to have lower ALT levels, although some had persistent ALT elevation during treatment. In conclusion, clinicians should pay attention to possible ALT elevation during the treatment of chronic hepatitis C patients. 相似文献
105.
Iikubo Masahiro Kagawa Toyohiro Fujisawa Junya Kumasaka Akira Nishioka Takashi Kojima Ikuho Sakamoto Maya Kobayashi Kaoru Yuasa Kenji 《Oral Radiology》2020,36(4):344-348
Oral Radiology - To ascertain the effects of exposure parameters (tube current and tube voltage) and the gutta-percha cone (GPC) size on root fracture-like artifacts obtained with cone-beam... 相似文献
106.
107.
108.
109.
Plasma interleukin-6 is associated with coagulation in poorly controlled patients with Type 2 diabetes. 总被引:2,自引:0,他引:2
Y Aso K Okumura N Yoshida K Tayama T Kanda I Kobayashi Y Takemura T Inukai 《Diabetic medicine》2003,20(11):930-934
AIMS: We investigated the relationship between interleukin (IL)-6 and coagulation, i.e. whether changes in the plasma IL-6 are associated with those in coagulation markers (D dimer and fibrinogen) after glycaemic control with sulphonylurea or insulin in poorly controlled patients with Type 2 diabetes. METHODS: We studied 42 patients with Type 2 diabetes, including 19 subsequently treated with sulphonylurea, 23 treated with insulin and 48 control subjects. All patients were in poor glycaemic control and were hospitalized for 3 weeks. At the beginning and end of treatment, we measured plasma concentrations of IL-6, fibrinogen, and D dimer. RESULTS: Plasma concentrations of IL-6 and D dimer were significantly higher in diabetic patients than in controls (P<0.0001 for both). In all patients with diabetes, the plasma concentration of IL-6 decreased significantly (P<0.001) after treatment. Changes in the plasma IL-6 during hospitalization were positively correlated with those in plasma D dimer and fibrinogen (r=0.664, P<0.0001; r=0.472, P=0.0042, respectively). Treatment with sulphonylurea or insulin caused a similar fall in the plasma IL-6 concentration with a concomitant decrease in the BMI and an equal improvement in glycaemia. CONCLUSIONS: In poorly controlled patients with Type 2 diabetes, plasma IL-6 concentrations were reduced significantly even by short-term metabolic control. As changes in the plasma concentrations of D dimer are related to plasma IL-6, plasma IL-6 may reflect a pro-coagulant as well as an inflammatory state in patients with Type 2 diabetes. 相似文献
110.
M. Kishimoto Dr. M. Hashiramoto S. Araki Y. Ishida T. Kazumi F. Kanda M. Kasuga 《Diabetologia》1995,38(2):193-200
Summary We screened 214 Japanese NIDDM (non-insulin-dependent) diabetic patients with a family history of diabetes for mutations in the mitochondrial tRNALeu(UUR) gene using polymerase chain reaction-restriction fragment length polymorphism and direct sequencing. Six patients were identified as having an A to G transition at position 3243 (3243 mutation), but no patients were detected with a T to C transition at position 3271, in the mitochondrial tRNALeu(UUR) gene. These two mutations were not present in 85 healthy control subjects. It was disclosed that the patients' mothers were also affected by diabetes mellitus in five of the six cases. In these six affected patients, the 3243 mutation shows variable phenotypes, such as the degree of multiple organ involvement, intrafamilial and interfamilial differences in disease characteristics, and the degree of the involvement of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) phenotype. Endocrinological examinations revealed that those diabetic patients with the 3243 mutation show not only beta-cell dysfunction, but also a defect in alpha-cell function, which is considered characteristic of diabetes with the 3243 mutation. When compared with 50 selected diabetic control subjects without the 3243 mutation, whose mothers, but not fathers, were found to have diabetes, it was established statistically that those with the 3243 mutation possess the following clinical characteristics; 1) the age of diabetes onset is lower, 2) they have lean body constitutions, and 3) they are more likely to be treated with insulin than control subjects. We suggest that diabetes with the 3243 mutation possesses phenotypes distinct from those in common forms of diabetes.Abbreviations NIDDM
non-insulin-dependent diabetes mellitus
- IDDM
insulin-dependent diabetes mellitus
- MELAS
mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
- PCR
polymerase chain reaction
- RFLP
restriction fragment length polymorphism
- BMI
body mass index
- ICA
islet cell antibody
- ICSA
islet cell surface antibody
- GAD
glutamic acid decarboxylase 相似文献